EVENTS · PCRX
PEERS
EARNINGS
No company news, with specialty and generic drug manufacturers higher as a group
| Series | 1W | 1M |
|---|---|---|
| PCRX | 0.0% | +47.0% |
| Peers | +1.4% | +7.4% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 28 | 100 |
Tender offer at $36.50 a share by Viatris Inc. Similar tender-offer deals closed 88% of the time (n=141), typically 46 days after announcement, around Nov 23 for this one. At $36.40, closing at the deal price would return 0.3% (about 5.3% a year to that date).
| Series | 1W | 1M |
|---|---|---|
| PCRX | 0.0% | +47.0% |
| Peers | +1.4% | +7.4% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 28 | 100 |
